Biochemical engineering approaches to the challenges of producing pure plasmid DNA.

Plasmid-based genes offer promise for a new generation of vaccines and for gene therapy, but the size and character of plasmids pose new challenges to biochemical engineers. By acknowledging these and using bioprocess-design information based on fundamental studies of the system's properties, it will be possible to create efficient and consistent processes for these materials. This review addresses the purity required, the key issue of the sensitivity of the chromosomal DNA contaminant and larger plasmids to hydrodynamic forces, and the impact of this and other characteristics of plasmids on the recovery and purification of DNA for pharmaceutical purposes.

[1]  E. Nabel,et al.  Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P Dunnill,et al.  Removal of contaminant nucleic acids by nitrocellulose filtration during pharmaceutical-grade plasmid DNA processing. , 2000, Journal of biotechnology.

[3]  D. Weiner,et al.  Modulating the immune response to genetic immunization , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  M. S. Levy,et al.  Quantitation of supercoiled circular content in plasmid DNA solutions using a fluorescence-based method. , 2000, Nucleic acids research.

[5]  M. Marquet,et al.  High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation. , 1996, Human gene therapy.

[6]  M. Yarmush,et al.  Metabolic engineering and human disease , 1997, Nature Biotechnology.

[7]  P Dunnill,et al.  The influence of precipitation reactor configuration on the centrifugal recovery of isoelectric soya protein precipitate , 1982, Biotechnology and bioengineering.

[8]  A. Mountain,et al.  Gene therapy: the first decade. , 2000, Trends in biotechnology.

[9]  Mike Hoare,et al.  Studies of the effect of shear on globular proteins: Extension to high shear fields and to pumps , 1981 .

[10]  P. Ayazi Shamlou,et al.  Processing of Solid–Liquid Suspensions , 1993 .

[11]  P. Cullis,et al.  Recent advances in liposomal drug-delivery systems. , 1995, Current opinion in biotechnology.

[12]  A Carlson,et al.  Mechanical disruption of Escherichia coli for plasmid recovery. , 1995, Biotechnology and bioengineering.

[13]  P Dunnill,et al.  Time course of SDS-alkaline lysis of recombinant bacterial cells for plasmid release. , 1998, Biotechnology and bioengineering.

[14]  H. Birnboim,et al.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA. , 1979, Nucleic acids research.

[15]  A. Porter,et al.  Therapeutic gene targeting , 1998, Gene Therapy.

[16]  Peter Dunnill,et al.  The processing of a plasmid-based gene from E. Coli. Primary recovery by filtration , 1997 .

[17]  Stephen A. Johnston,et al.  The Scientific Future of DNA for Immunization , 1997 .

[18]  D J Porteous,et al.  Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation. , 1996, Gene therapy.

[19]  G. Pierce,et al.  Targeting bacteriophage to mammalian cell surface receptors for gene delivery. , 1998, Human gene therapy.

[20]  R. Schleif,et al.  Size fractionation of double-stranded DNA by precipitation with polyethylene glycol. , 1975, Nucleic acids research.

[21]  M. Marquet,et al.  Quantitation of host cell DNA contaminate in pharmaceutical-grade plasmid DNA using competitive polymerase chain reaction and enzyme-linked immunosorbent assay. , 1998, Human gene therapy.

[22]  S. Ståhl,et al.  Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. , 1999, Journal of biotechnology.

[23]  E. Livanos,et al.  A system for shuttling 200-kb BAC/PAC clones into human cells: stable extrachromosomal persistence and long-term ectopic gene activation. , 1998, Human gene therapy.

[24]  H. Willard.  Human artificial chromosomes coming into focus , 1998, Bio/Technology.

[25]  Peter Dunnill,et al.  Methods of enhancing the recovery of plasmid genes from neutralised cell lysate , 1999 .

[26]  M. Hoare,et al.  INTERFACIAL DAMAGE TO PROTEINS DURING INTENSIVE MIXING IN FERMENTATION AND DOWNSTREAM PROCESSING , 1993 .

[27]  M. S. Levy,et al.  Rapid quantitation and monitoring of plasmid DNA using an ultrasensitive DNA-binding dye. , 1999, Biotechnology and bioengineering.

[28]  E Keshavarz-Moore,et al.  Effects of growth medium selection on plasmid DNA production and initial processing steps. , 2000, Journal of biotechnology.

[29]  R. K. Evans,et al.  Analysis of plasmid DNA from a pharmaceutical perspective. , 1998, Journal of pharmaceutical sciences.

[30]  Nigel J. Titchener-Hooker,et al.  The effects of material properties and fluid flow intensity on plasmid DNA recovery during cell lysis , 1999 .

[31]  J. Lis.  Fractionation of DNA fragments by polyethylene glycol induced precipitation. , 1980, Methods in enzymology.

[32]  P Dunnill,et al.  Action of shear on enzymes: Studies with catalase and urease , 1979, Biotechnology and bioengineering.

[33]  P. Dunnill,et al.  The performance of a scaled down industrial disc stack centrifuge with a reduced feed material requirement , 1998 .

[34]  P. Ayazi Shamlou,et al.  Characterisation of plasmid DNA conjugates as a basis for their processing , 1999 .

[35]  S. Charm,et al.  Shear effects on enzymes , 1981 .

[36]  C. Newgard.  Cellular Engineering for the Treatment of Metabolic Disorders: Prospects for Therapy in Diabetes , 1992, Bio/Technology.

[37]  R Hjorth,et al.  Direct visualisation of plasmid DNA in individual chromatography adsorbent particles by confocal scanning laser microscopy. , 1999, Journal of chromatography. A.

[38]  P. Ayazi Shamlou,et al.  Effect of shear on plasmid DNA in solution , 1999 .

[39]  D. Clewell,et al.  Nature of Col E1 Plasmid Replication in Escherichia coli in the Presence of Chloramphenicol , 1972, Journal of bacteriology.

[40]  C. Cooney,et al.  Preparative purification of supercoiled plasmid DNA using anion-exchange chromatography. , 1998, Journal of chromatography. A.

[41]  P. Ayazi Shamlou,et al.  Rheological properties of chromosomal and plasmid DNA during alkaline lysis reaction , 1999 .

[42]  M. Marquet,et al.  Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. , 1995, Human gene therapy.

[43]  Emil L. Smith.  Principles of Biochemistry: General Aspects , 1983 .

[44]  T. Friedmann.  The road toward human gene therapy--a 25-year perspective. , 1997, Annals of medicine.

[45]  Eastman,et al.  Manufacturing and quality control of plasmid-based gene expression systems. , 1998, Advanced drug delivery reviews.

[46]  K. Moelling,et al.  Therapy of tuberculosis in mice by DNA vaccination , 1999, Nature.

[47]  Richard C. Willson,et al.  Purification of plasmid DNA using selective precipitation by compaction agents , 1999, Nature Biotechnology.

[48]  H. Söderlund,et al.  Escherichia coli plasmid production in fermenter , 1989, Biotechnology and bioengineering.

[49]  D. Scherman,et al.  Efficient purification of plasmid DNA for gene transfer using triple-helix affinity chromatography , 1997, Gene Therapy.

[50]  Ryusuke Inoue,et al.  Increase in negative supercoiling of plasmid DNA in Escherichia coli exposed to cold shock , 1997, Molecular microbiology.